Last reviewed · How we verify

NCT03792581: COMAT

COntrolled MAp Trauma Brain Injury (COMAT Study)

Withdrawn NA Last updated 14 May 2019
What this trial tests

NA trial testing EV1000 and closed-loop system in Closed-Loop Communication. Withdrawn.

Timeline
1 April 2019
Primary endpoint
30 December 2019
30 December 2019

Quick facts

Lead sponsorErasme University Hospital
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Start date1 April 2019
Primary completion30 December 2019
Estimated completion30 December 2019
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Erasme University Hospital

Who can join

Adults 18 to 99, any sex, with Closed-Loop Communication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this randomized controlled trial will be to show that the use of a novel automated system to guide vasopressor administration in head trauma injury patients will results in more time spent with a mean arterial pressure (MAP) within the predefined MAP compared to patients managed without any automated system (manually management)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of EV1000 and closed-loop system

Trials testing the same drug.

Other Erasme University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03792581.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing